[1]
Grozman, V. et al. 2021. Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc – effects and side effects. Acta Oncologica. 60, 3 (Apr. 2021), 305–311. DOI:https://doi.org/10.1080/0284186X.2020.1866776.